STOCK TITAN
  1. Home
  2. Sec-filings
  3. NUTX
  4. [Form 4] Nutex Health, Inc. Insider Trading Activity

Nutex Health (NUTX) CFO adds shares through RSU grant and exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nutex Health Inc. Chief Financial Officer Jon Christian Bates reported compensation-related equity activity. He acquired 2,667 shares of common stock through a derivative exercise, bringing his direct common stock holdings to 8,305 shares. He was also granted 1,694 restricted stock units, which convert into common stock on a one-for-one basis and vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, increasing his restricted stock unit balance to 5,527 units. These transactions reflect equity compensation and derivative exercises, not open-market buying or selling.

Positive

  • None.

Negative

  • None.
Insider Bates Jon Christian
Role Chief Financial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 1,694 $0.00 --
Exercise Common Stock 2,667 $0.00 --
Holdings After Transaction: Restricted Stock Units — 5,527 shares (Direct); Common Stock — 8,305 shares (Direct)
Footnotes (1)
  1. Restricted stock units convert into common stock on a one-for-one basis. On March 11, 2026, the Reporting Person was granted 1,694 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bates Jon Christian
(Last) (First) (Middle)
1776 YORKTOWN STREET
SUITE 700
(Street)
HOUSTON TX 77056
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/10/2026 M 2,667(1) A $0(1) 8,305 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 03/11/2026 M 1,694(1) 03/01/2027(2) 03/01/2029(2) Common Stock 1,694 $0 5,527 D
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
2. On March 11, 2026, the Reporting Person was granted 1,694 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
/s/ Jon Bates 03/11/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Nutex Health (NUTX) report for its CFO?

Nutex Health’s CFO Jon Christian Bates reported acquiring 2,667 common shares through a derivative exercise and receiving 1,694 restricted stock units as equity compensation, all held directly rather than via a trust or other entity.

How many Nutex Health (NUTX) shares does the CFO hold after these transactions?

After the reported transactions, CFO Jon Christian Bates directly holds 8,305 shares of Nutex Health common stock and 5,527 restricted stock units that convert one-for-one into common shares as they vest over future dates.

Were the Nutex Health (NUTX) CFO transactions open-market buys or sells?

The reported transactions were not open-market buys or sells. They consist of a derivative exercise acquiring 2,667 common shares and an award of 1,694 restricted stock units as part of the CFO’s equity compensation package.

What are the vesting terms of the Nutex Health (NUTX) CFO’s new RSU grant?

The CFO’s 1,694 restricted stock units vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029. Each vested RSU converts into one share of Nutex Health common stock upon settlement.

Does the Nutex Health (NUTX) CFO have direct ownership of the reported shares and RSUs?

Yes. The filing classifies all reported holdings as directly owned by CFO Jon Christian Bates. There is no indication the shares or restricted stock units are held through a trust, LLC, or other indirect ownership vehicle.